MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
1485.22%
Quick Ratio
1485.22%
Cash Ratio
1463.69%
Debt to Asset Ratio
13.70%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Operating right-of-use asset
    • Restricted cash
    • Other assets
Liabilities Breakdown
    • Additionalpaid-incapital
    • Accumulated deficit
    • Term loan,non-current
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
243,733
263,762
176,484
137,816
Prepaid expenses and other current assets
3,586
5,364
1,234
1,632
Total current assets
247,319
269,126
177,718
139,448
Restricted cash
500
500
500
500
Property and equipment, net
2,051
2,234
1,872
2,029
Operating right-of-use asset
3,858
4,061
4,261
4,459
Other assets
338
338
338
570
Total assets
254,066
276,259
184,689
147,006
Accounts payable
4,021
3,369
1,878
2,059
Accrued expenses and other current liabilities
8,863
7,610
8,862
6,986
Term loan, current
3,768
2,136
585
-
Total current liabilities
16,652
13,115
11,325
9,045
Term loan,non-current
12,419
13,885
16,172
20,314
Convertible grant agreement
2,465
2,335
2,227
2,124
Lease liability, long-term
3,281
3,555
3,823
3,966
Total liabilities
34,817
32,890
33,547
35,449
Common stock (par value 0.0001), 500,000 shares authorized 35,094 and 31,924 shares issued and outstanding as of june30, 2026 and december31, 2025, respectively
3
3
3
3
Additionalpaid-incapital
474,738
471,224
352,751
296,992
Accumulated deficit
-255,509
-227,871
-201,634
-185,452
Accumulated other comprehensive loss
17
13
22
14
Total stockholders equity
219,249
243,369
151,142
111,557
Total liabilities and stockholders equity
254,066
276,259
184,689
147,006
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$243,733K (65.15%↑ Y/Y)Prepaid expenses andother current assets$3,586K (58.60%↑ Y/Y)Total current assets$247,319K (65.05%↑ Y/Y)Operating right-of-useasset$3,858K (-17.09%↓ Y/Y)Property and equipment,net$2,051K (-11.14%↓ Y/Y)Restricted cash$500K (0.00%↑ Y/Y)Other assets$338K (-40.70%↓ Y/Y)Total assets$254,066K (60.93%↑ Y/Y)Total liabilities andstockholders equity$254,066K (60.93%↑ Y/Y)Total stockholdersequity$219,249K (77.66%↑ Y/Y)Total liabilities$34,817K (1.02%↑ Y/Y)Accumulated deficit-$255,509K (-49.18%↓ Y/Y)Additionalpaid-incapital$474,738K (61.12%↑ Y/Y)Total currentliabilities$16,652K (104.85%↑ Y/Y)Termloan,non-current$12,419K (-38.28%↓ Y/Y)Lease liability,long-term$3,281K (-22.14%↓ Y/Y)Convertible grant agreement$2,465K (23.25%↑ Y/Y)Accumulated othercomprehensive loss$17K (-45.16%↓ Y/Y)Common stock (par value0.0001), 500,000 shares...$3K (0.00%↑ Y/Y)Accrued expenses andother current...$8,863K (37.24%↑ Y/Y)Accounts payable$4,021K (140.63%↑ Y/Y)Term loan, current$3,768K

Alto Neuroscience, Inc. (ANRO)

Alto Neuroscience, Inc. (ANRO)